Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30000 participants
OBSERVATIONAL
2023-03-10
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
30,000 children aged 3-18 years were examined with cycloplegia to collect their ocular parameters and were all followed up for three years with annual visits.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-myopes
To collect the ocular data among non-myopic children.
No interventions assigned to this group
Myopes
To collect the ocular data among myopic children.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been lived in the research areas for at least one year, and will not move to other places in the following two years
* Parents or guardians sign an informed consent form, and children over 6 years old need oral consent to participate
Exclusion Criteria
* Ophthalmic diseases, inability to cooperate to complete the inspection
3 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Sichuan Provincial People's Hospital
OTHER
Shandong University of Traditional Chinese Medicine
OTHER
People's Hospital of Ningxia Hui Autonomous Region
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
The First Affiliated Hospital of Guangxi Traditional Chinese Medical University
UNKNOWN
Affiliated Hospital of Inner Mongolia Minzu University
UNKNOWN
Xinjiang Hospital of Traditional Chinese Medicine
UNKNOWN
Shanghai Eye Disease Prevention and Treatment Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jiannan Huang
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xun Xu, MD
Role: primary
Xiangui He
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NO.CALS20220101
Identifier Type: -
Identifier Source: org_study_id